Dr. Rana Ramzi McKay, MD
- Medicare services, 2024
- 637
- Medicare patients, 2024
- 225
- Part D claims, 2024
- 359
- Publications
- 263
- Clinical trials
- 10
- Practice address
- 200 W Arbor Dr, San Diego, CA 92103
- Practice phone
- Call (619) 543-6222
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
UCSD Hillcrest Medical Center
San Diego, California
Find Dr. McKay's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rana Ramzi McKay is a hematologist and oncologist in San Diego, California
Dr. McKay practices at UCSD Hillcrest Medical Center in San Diego, California.
Dr. McKay's NPI, 1306013610, was assigned on May 15, 2008. Dr. McKay graduated from University Of Florida College Of Medicine in 2008. Dr. McKay holds California license A145444.
- NPI
- 1306013610NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1557538626
- NPI enumeration date
- May 15, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (619) 543-6222
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 44
- Medical school graduation
- 2008
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rana Ramzi McKay practices at UCSD Hillcrest Medical Center in San Diego, California
Dr. McKay's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.
- UCSD Hillcrest Medical Center200 W Arbor Dr, San Diego, CA 92103 · San Diego CountyPhone(619) 543-6222
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Rana Ramzi McKay is affiliated with 2 sites of care and 1 medical group
Dr. McKay's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. McKay is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Rana Ramzi McKay's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKay practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UCSD Hillcrest Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rana Ramzi McKay is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. McKay's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. McKay is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. McKay's licenses on file in 2 states: California and Massachusetts.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- Internal medicine, Massachusetts
Clinical focus
Dmand AI lists breast cancer, chronic anemia, lymphoma and prostate cancer among the conditions Dr. McKay treats.
Hematologists and oncologists near Dr. McKay
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rana Ramzi McKay billed Medicare for 637 services in 2024
CMS data shows 637 Medicare services from Dr. McKay across 4 procedure codes in 2024, for 225 Medicare patients. Medicare paid $61,639 for them.
Dr. McKay's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7622024: 63716%
Where Dr. McKay's Medicare services took place, 2024
- In an office20031%
- In a facility43769%
Dr. McKay compared with the California median for hematologists and oncologists, 2024
- Dr. McKay
- California median
- Medicare services
- 637vs 93232% below
- Medicare patients
- 225vs 225Close to median
- Part D claims
- 202vs 39449% below
Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.
Dr. McKay's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. McKay?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. McKay and other hematologists and oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rana Ramzi McKay treated 225 Medicare patients in 2024, average age 74
CMS counts 225 Medicare patients who saw Dr. McKay in 2024. The largest group is 75 to 84, with 104 patients. 75% of them have cancer, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. McKay's median patient age at 73, with 11% women.
Dr. McKay's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. McKay's Medicare patients by sex, 2024
- Women146%
- Men21194%
Chronic conditions among Dr. McKay's Medicare patients, 2024
- Cancer75%
- High cholesterol72%
- High blood pressure70%
- Arthritis39%
- Chronic kidney disease36%
- Ischemic heart disease36%
- Diabetes25%
- Osteoporosis25%
Share of Medicare patients with each condition. A patient can have several.
Dr. McKay's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women11%
- Men88%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rana Ramzi McKay wrote 359 Medicare Part D claims in 2024
In 2024, Dr. McKay wrote 359 Medicare Part D claims for 92 patients. 65% of them were for generic drugs. CMS names the drug for 202 of them, across 8 drugs with 11 or more claims each, at $735,640 in total drug cost. In 2023, CMS named 329 claims across 15 drugs.
Dr. McKay's Part D claims by kind of drug, 2024
- Generic235 claims65%
- Brand-name124 claims35%
Dr. McKay's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. McKay's Part D claims, 2024
- Opioids6%20 of 359 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3292024: 20239%
Drugs named by CMS: 8 in 2024, 15 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rana Ramzi McKay scored 91 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. McKay for performance year 2024, reported as part of a group. Dr. McKay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKay as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. McKay's MIPS scores, performance year 2024
- 91of 100Final score
- 84.1of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rana Ramzi McKay has 263 publications on record
Dmand AI links 263 papers to Dr. McKay, published from 2013 to 2025. 2024 was the busiest year, with 33. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Prostatic Neoplasms. Dr. McKay has published most often in Clin Genitourin Cancer. Dr. McKay's most frequent co-authors are Toni K. Choueiri, MD, Brent Shane Rose, MD and Mehmet Asim Bilen, MD.
Dr. McKay's papers by year, 2016 to 2025
Topics Dr. McKay writes about most
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Androgen Antagonists
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Immune Checkpoint Inhibitors
Dr. McKay's most frequent co-authors
- Toni K. Choueiri, MD79 shared papers
- Brent Shane Rose, MD41 shared papers
- Mehmet Asim Bilen, MD25 shared papers
Recent publications by Dr. McKay
See who Dr. McKay researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McKay works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rana Ramzi McKay has worked on 10 clinical trials
Dmand AI links Dr. McKay to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. McKay that name 1 trial.
Clinical trials with Dr. McKay by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- 4Phase 2: 4 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. McKay's trials
- Prostatic Neoplasms
- Prostatic Diseases
- Carcinoma, Renal Cell
- Neoplasm Metastasis
- Kidney Neoplasms
Investigators on the most trials with Dr. McKay
- Adam C. Olson, MD2 shared trials
- Christopher M. Pieczonka, MD2 shared trials
- Sanjay Sharma, MD2 shared trials
Recent clinical trials with Dr. McKay
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (opens in a new tab)
Improving Germline Testing in At-Risk Patients With Prostate Cancer (opens in a new tab)
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Rana Ramzi McKay received $551,737 in industry payments from 2016 to 2025
CMS Open Payments shows 412 general payments to Dr. McKay from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Merck Sharp & Dohme Corporation paid the most, $121,625. It also lists 18 research payments totaling $18,041 from 2022 to 2025, naming 1 clinical trial.
General payments to Dr. McKay by program year, 2016 to 2025
General payments to Dr. McKay by kind, 2016 to 2025
- Consulting fees$376,21968%
- Speaker and faculty fees$105,62619%
- Honoraria$32,2306%
- Travel and lodging$29,4195%
- Other$8,2431%
Companies that paid Dr. McKay the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Rana Ramzi McKay graduated from University Of Florida College Of Medicine
Dr. McKay graduated from University Of Florida College Of Medicine in 2008. Dr. McKay is a member of ASCO.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Rana Ramzi McKay accepts plans from 16 insurance carriers
Dr. McKay is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Elevance
- HCSC
- Humana
- Aetna
- Blue Cross Blue Shield of Massachusetts
- Molina
- +8 more carriersWith a free account
Plan types Dr. McKay accepts, by number of carriers
- PPO10
- HMO8
- Medicare8
- EPO3
- POS2
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Rana Ramzi McKay's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rana Ramzi McKay
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rana Ramzi McKay's NPI number?
Dr. Rana Ramzi McKay's NPI number is 1306013610. It was assigned on May 15, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Rana Ramzi McKay?
Dr. Rana Ramzi McKay is a hematologist and oncologist in San Diego, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Rana Ramzi McKay practice?
Dr. McKay practices at 200 W Arbor Dr, San Diego, CA 92103. Dr. McKay's primary practice is UCSD Hillcrest Medical Center in San Diego, California.
What is Dr. Rana Ramzi McKay's office phone number?
The practice phone on file for Dr. McKay is (619) 543-6222.
What is Dr. Rana Ramzi McKay's medical license number?
Dr. McKay holds California license A145444, one of the licenses on file in 2 states.
Which states has Dr. Rana Ramzi McKay been licensed in?
Dmand AI has state licenses on file for Dr. McKay in California (2016 to 2026) and Massachusetts (2011 to 2018).
Which hospitals is Dr. Rana Ramzi McKay affiliated with?
Dr. McKay is affiliated with Hillcrest Medical Center.
What medical group is Dr. Rana Ramzi McKay part of?
Dr. McKay is linked to UC San Diego Health.
Does Dr. Rana Ramzi McKay accept Medicare?
Yes. CMS data shows Dr. McKay billed Medicare for 637 services in 2024, and Dr. McKay accepts Medicare assignment.
Does Dr. Rana Ramzi McKay offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. McKay as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Rana Ramzi McKay's MIPS score?
Dr. McKay's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.
How many Medicare patients does Dr. Rana Ramzi McKay see?
CMS counts 225 Medicare patients who saw Dr. McKay in 2024, with an average age of 74.
Is Dr. Rana Ramzi McKay board certified?
Yes. Dr. McKay is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Rana Ramzi McKay bill to Medicare?
In 2024, Dr. McKay's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and care management and other visits (99497).
Where did Dr. Rana Ramzi McKay go to medical school?
Dr. McKay graduated from University Of Florida College Of Medicine in 2008.
What drugs does Dr. Rana Ramzi McKay prescribe most?
In 2024 Medicare Part D data, Dr. McKay's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Orgovyx.
Has Dr. Rana Ramzi McKay received payments from drug or device companies?
CMS Open Payments shows $551,737 in general payments to Dr. McKay from 28 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Rana Ramzi McKay been practicing?
Dr. McKay graduated from medical school in 2008, 18 years ago.
Does Dr. Rana Ramzi McKay do research?
Dmand AI links 263 publications to Dr. McKay, published from 2013 to 2025. Dr. McKay has worked on 10 clinical trials.
Who does Dr. Rana Ramzi McKay publish with?
Dr. McKay's most frequent co-authors are Toni K. Choueiri, MD (79 shared papers), Brent Shane Rose, MD (41 shared papers) and Mehmet Asim Bilen, MD (25 shared papers).
What insurance does Dr. Rana Ramzi McKay accept?
Dr. McKay is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card